Index Entries

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients

https://www.sciencedirect.com/science/article/pii/S2052297523001075

Philippe Brouqui, Matthieu Million, Philippe Parola, Peter A. McCullough, and Didier Raoult
October 30, 2023
New Microbes and New Infections
Aix-Marseille Université (France)

"Results: Among 30,202 patients for whom information on treatment was available, 191/23,172 (0.82%) patients treated with HCQ-AZ died, compared to 344/7030 (4.89%) who did not receive treatment with HCQ-AZ.

Conclusion: Analysis of this large online database showed that HCQ-AZ was consistently associated with the lowest mortality."

© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

document
COVID-19,hydroxychloroquine,medical treatments,pharmaceuticals